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Abstract
The lack of toxicological data on nanomaterials makes it difficult to assess the risk related 
to their exposure, and as a result further investigation is required. This chapter presents 
the synthesis of controlled oxide nanoparticles followed by the evaluation of their safety 
profile or toxicity (iron, titanium and zinc oxides). The controlled surface chemistry, dis-
persion in several media, morphology and surface charge of these nanoparticles are pre-
sented (transmission electron microscopy, dynamic light scattering, zeta potential, X-ray 
photoelectron spectroscopy). Classical cytotoxic and cellular uptake studies on different 
cancer cell lines from liver, prostate, heart, brain and spinal cord are discussed. The inci-
dence of nanoparticles on biogenesis and activity of cell organelles is also highlighted, 
as well as their biodistribution in animal models. The acute toxicity on zebrafish embryo 
model is also presented. Finally, the stress is put on the influence and the necessity of 
controlling the protein corona, a layer of plasma proteins physically adsorbed at the sur-
face of such nanoparticles as a result of their presence in the bloodstream (or relevant 
biological fluids).
Keywords: superparamagnetic iron oxide nanoparticles (SPIONs), titanate nanotubes 
(TiONts), zinc oxide, cytotoxicity, oxidative stress, cell organelle activity, zebrafish, 
cellular uptake, biodistribution, protein corona
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1. Introduction
The development and production of nanomaterials are one of the fastest growing areas of 
advanced technologies, providing a wide range of novel applications in the electronic, health-
care, cosmetic, agronomy, engineering and food industries. The nanotechnology era has 
increased nanoparticles concentration in the environment, causing continuous human expo-
sure, with both uncontrolled contact by inhalation or through the skin, as well as exposure via 
oral administration or by drug injection.
The lack of toxicological data on nanomaterials makes it difficult to assess the risk due to their 
exposure. For all these reasons, there is an urgent need to develop rapid, accurate and effective 
testing strategies to assess the impact of these emerging materials on human health and the envi-
ronment. Three nanoparticles of growing interest have been selected as key materials in this chap-
ter: (1) superparamagnetic iron oxide nanoparticles (SPIONs) that are commonly developed as 
magnetic resonance imaging (MRI) contrast agents [1], (2) titanate nanotubes (TiONts) for their 
elongated morphology [2] and (3) ZnO nanoparticles, known for their potential hazards [3].
The major objective of this study concerns the detailed assessment of oxide nanoparticles 
toxicity or safety profile, through the development of pertinent bioassays. Cytotoxicity assays 
to check cellular homeostasis disruption, transmission electron microscopy (TEM) analysis 
and flow cytometry for particle uptake investigation, cell death evaluation, and the influence 
of nanoparticles on biogenesis and activity of cell organelles are described. Moreover, eco-
toxicological monitoring was performed using zebrafish embryos as a model. Survival and 
hatching rates, and malformations were determined upon exposure to oxide nanoparticles. 
Finally, an understanding and factors to control the protein/nanomaterial interactions are fur-
ther presented. These proteins influence the cellular interactions with the nanoparticles such 
as adhesion to the plasma membrane or uptake, but also their biodistribution.
2. Synthesis, purification and characterization tools for oxide 
nanoparticles toxicity control and profiling
To investigate the toxicological risk assessment of nanomaterials, it is necessary to jointly con-
trol their morphology, their size distribution, the nature of their interfaces (charges and chem-
istry) and their colloidal stability in several media. Indeed, many controversies in literature 
come from the lack of control of one of these parameters. In this part, the emphasis is placed 
on the synthesis as well as the characterization tools used to fully investigate nanoparticles 
and to control the parameters influencing their nanotoxicity.
2.1. Synthesis routes of oxide nanoparticles: the case of SPIONs and TiONts
2.1.1. Synthesis of SPIONs by soft chemistry as well as functionalization of their surface
SPIONs were prepared according to a method derived from the classical Massart protocol [4]. 
Briefly, a 1:2 molar ratio of ferrous and ferric chloride was added to a NaOH solution at 90°C 
under vigorous mechanical stirring. The product was magnetically settled down and washed 
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three times with 400 mL of 1 M HNO3. Finally, the particle suspension was centrifuged at 450× g for 1 h to remove the biggest aggregates. The supernatant was dialyzed against an 
HNO3 solution (pH 4.0) during 24 h [5].
In order to increase their colloidal stability for biological assays, bare SPIONs were subjected to 
3-aminopropyltriethoxysilane (APTES) in an equivalent mass ratio into a 1:1 ethanol/water mix-
ture, the pH of which was decreased to 4.0 by the addition of 1 M HCl prior to the APTES addi-
tion. The mixture was submitted to an ultrasonic treatment to afford a good particle dispersion 
leading to the polysiloxane coverage of individual particles rather than agglomerates. The mix-
ture was then submitted to mechanical stirring during 48 h. Glycerol was then added followed 
by the evaporation of the ethanol/water mixture under reduced pressure to increase the polysi-
loxane condensation around SPIONs. Finally, glycerol was removed by acetone addition to the 
SPION suspension accompanied by a magnetic decantation. SPIONs were finally resuspended 
into ultrapure water yielding SPIONs-NH2 and dialyzed 1 week against ultrapure water [6].
The surface of bare SPIONs or SPIONs-NH2 was then functionalized with polyvinyl alco-hol (PVA) or polyethylene glycol (PEG-COOH), respectively. Polymers of different molecular 
weights (from 2 to 30 kDa) and bearing different chemical groups were used. PEG chains were 
covalently grafted on the surface of SPIONs (EDC/NHS coupling), while PVA was linked via 
electrostatic interactions [7].
2.1.2. Synthesis of TiONts and functionalization of their surface
Titanate nanotubes were prepared by a classical hydrothermal method. Titanium dioxide rutile 
precursor powders (440 mg) were added to a NaOH aqueous solution (10 mol.L−1, 110 mL) 
[2]. The mixture was subjected to ultrasound (15 min, 375 W) before being transferred into a 
sealed Teflon reactor. The temperature was set at 155°C for 36 h and the mixture was stirred by 
magnetic stirring (120 rpm). The resulting white product was isolated by centrifugation and 
washed with deionized water until pH 6.0 was reached. Finally, the powder was freeze-dried.
The biocompatibility of TiONts in biological systems has been improved through their sur-
face modification with APTES, PEG or chitosan grafting. Bare TiONts were coated by APTES 
and PEG with protocols very similar to that used for SPIONs [8]. The method of chitosan 
(CT) grafting is based on electrostatic interactions between chitosan’s amines and nanotubes’ 
hydroxyl groups. Briefly, a mixture of TiONts and CT in a 1:2 molar ratio of TiONts(–OH)/
CT(–NH2) was prepared and the pH was adjusted to 7.0. The suspension was mixed up at 25°C under magnetic stirring during 24 h. The powder was washed several times with deion-
ized water by an ultrafiltration device (300 kDa, regenerated cellulose) [9].
2.2. Purifications of bare nanoparticles and nanohybrids
Purification of nanoparticles is undoubtedly an important and challenging step in order 
to control both the chemistry of their surface and their dispersion in varied media. All the 
obtained nanohybrids were purified by ultrafiltration on 30 kDa membranes and/or dialyzed 
on 3.5 kDa membranes to remove ungrafted stabilizing molecules and remaining salts finally 
yielding nanoparticle suspensions at the pH and the conductivity of ultrapure water. Finally, 
a portion of the suspensions was freeze-dried for powder characterizations: X-ray diffraction 
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(XRD), infrared spectroscopy (IR), X-ray photoelectron spectroscopy (XPS) and thermogravi-
metric analysis (TGA) [8, 10, 11].
2.3. Importance of high-standard characterization tools for nanotoxicity evaluation 
and safety profile definition
It is well known that numerous parameters influence the toxicity of nanomaterials. This is the 
reason why each kind of nanoparticles (bare or coated-SPIONs, TiONts or ZnO) was thoroughly 
characterized by an array of analytical techniques, which allowed to keep track of the precise 
morphology, composition, agglomeration and surface chemistry (composition and charge). We 
ensured the highest standards of characterization of hybrid nanomaterials (Figure 2).
The size and morphology of the individual nanoparticles were determined by transmission 
electron microscopy (TEM) and scanning electron microscopy (SEM). The agglomeration 
state was investigated via dynamic light scattering (DLS) and specific surface area measure-
ments (BET method). The colloidal stability was investigated by UV-visible spectroscopy in 
several media (e.g., PBS, MEM and albumin solutions): the UV absorbance evolution was 
recorded over time every 5 min during several hours. The faster the absorbance decreased, the 
less stable the particles were in suspension [9, 10].
The oxide nanoparticles structure was investigated by X-ray diffraction (XRD), high resolu-
tion TEM, selected area diffraction (SAD), Raman and FTIR spectroscopies. The nanoparticles 
chemistry was also analyzed by inductively coupled plasma atomic emission spectroscopy 
(ICP-AES) (Figure 2) [6].
Moreover, the chemical composition of the nanoparticles surface was investigated through 
XPS, TGA, zeta potential measurements and FTIR spectroscopy. For instance, XPS was associ-
ated with TGA to quantify the molecule number grafted at the surface of nanohybrids [12].
3. Cytotoxicity, cellular uptake and biodistribution of oxide 
nanoparticles
The previously described metal oxide nanoparticles are excellent candidates for a variety of 
biomedical applications ranging from drug delivery to diagnostic aids, as well as implantable 
biomaterials [6, 8, 13, 14]. However, a thorough evaluation of particles interaction with the tar-
geted cells, circulatory immune cells and tissues is the first prerequisite. Here, these interactions 
are presented from an internalization and cytotoxicity point of view, and the biodistribution of 
these particles in various in vivo models (healthy and tumor bearing rodents) is also highlighted.
3.1. Superparamagnetic iron oxide nanoparticles: toxicity, cellular interactions and 
biodistribution
3.1.1. Cytotoxicity of SPIONs
SPIONs are well developed for biomedical applications as a consequence of their easy and 
reproducible production. Another advantage of the SPIONs is their chemistry. They are in fact 
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made from one of the most abundant metals present in metabolism: iron. Despite the fact that 
iron could induce ROS generation in cells [15], working with this element clearly decreases the 
potential toxicity compared to other metal oxide nanoparticles during dissolution processes 
in vitro or in vivo [15]. Naked SPIONs tend to sediment and can precipitate at physiological 
conditions, leading to a severe toxicological hazard [16]. It is imperative to modify the surface 
of these nanoparticles to avoid any aggregation and the resultant risk of toxicity. Polyethylene 
glycol (PEG) is a polymer commonly used to increase the biocompatibility of the SPIONs as 
well as their stealthiness for specific targeting [17]. SPIONs grafted with PEG do not show 
any cytotoxicity via MTT assay at a concentration up to 270 µgFe/mL, 24 h after incubation 
with RAW 264.7 and HepG2 cell lines [5]. Polyvinyl alcohol (PVA) is also used to stabilize 
SPIONs and do not have any cytotoxic effects (MTS assay) for a concentration of 800 μgFe/mL 
24 h after incubation with RAW 264.7 cells [18]. Furthermore, PVA coated SPIONs do not sig-
nificantly activate or influence human T helper cells and have a negligible influence on T cell 
apoptosis at a concentration of 100 μgSPIONs/mL after 72 h [19]. Regarding PVA, the covalent 
binding of this polymer onto the SPION surface significantly decreases some inflammatory 
effects on same T helper cells [20]. Evaluating cytotoxicity of SPIONs is not a trivial operation. 
Many tests are measuring the evolution of absorbance and the nanomaterials are influencing 
the final value. It is then very important in order to avoid false positive or negative results, to 
carefully setup the experiments and the control to correct the absorbance [21].
As demonstrated in many studies, the addition of a biocompatible polymer layer on the 
SPION surface significantly improves their biocompatibility, which is a crucial step for the 
biological interactions targeted.
3.1.2. Cellular uptake and biodistribution of superparamagnetic iron oxide nanoparticles
First of all, the magnetic properties of SPIONs are very interesting to increase the cellular uptake 
rate of these nanoparticles with a magnet [22] and then to improve the labeling of cells for bio-
medical applications [23, 24]. The concentration and the charge play a significant role in the cel-
lular internalization [25]. For instance, negatively charged fluorescently labeled SPIONs have a 
higher internalization in prostate-cancer PC-3 cell line as observed via confocal microscopy or 
flow cytometry, in comparison to positively charged SPIONs [26]. In the same way, neutrally 
charged SPIONs coated with PEG show less cellular interactions on RAW 264.7 cells by TEM and 
classical microscopy (labeled with Prussian blue) than negatively charged PEGylated-SPIONs 
[5]. On another side, positively charged PVA-SPIONs seem to have a better internalization by 
HeLa cells than neutral PVA-SPIONs with an additional influence of the culture medium used, 
especially depending on the presence of proteins [7]. Thus, the influence of the chemical coating 
is an important factor, however it seems that the nature of the medium used is much more critical.
Regarding their biodistribution, SPIONs usually show accumulation in the liver and spleen 
[1, 27]. SPION accumulation to the liver is delayed due to a coating of neutral PEG onto 
SPIONs, as observed by MRI and Prussian blue-based histology [5]. Their circulation time 
in the bloodstream is at least 3 h longer compared to negatively charged PEG-SPIONs [5]. 
The charge of PVA conjugated particles can also induce different in vivo behavior of SPIONs. 
When observed 15 min after injection into a rat model, 50% of the dose of positively charged 
PVA-SPIONs already accumulate in the liver when 90% of the neutral and the negatively 
charged PVA-SPIONs are still passing through the bloodstream [28].
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Overall, SPIONs are well developed and tested for many biological applications. They do 
not show any dramatic toxicity and have interesting cellular and in vivo interactions, making 
them extremely attractive as theranostic agents [29].
3.2. Titanate nanotube in vitro toxicity and biodistribution testing
3.2.1. Cytotoxicity of TiONts: the surface chemistry matters
The cytotoxicity of titanate nanotubes made by hydrothermal treatment has been assessed 
in H596 human lung tumor cells [30], cardiomyocytes [31], SNB19 and U87-MG glioblasto-
mas [32], Caco-2 cells [33], as well as 22Rv1 prostate cancer cells [8]. Interestingly, the degree 
of ion exchange via acid treatment, which partly or entirely substitutes sodium cations by 
hydrogen cations, is a key parameter that drives the cytotoxicity of titanate nanowires [30]. 
Titanate nanotubes that were not treated with acid did not induce significant cytotoxic effect 
in cardiomyocytes, as seen by MTT assay performed between 1 and 10 μg/mL TiONts [31]. 
Similarly, TiONts concentration ranging up to 100 μg/mL do not induce detectable cytotoxic-
ity in glioblastoma cell lines [32]. In contrast, the viability of CHO cells significantly decreases 
to 66% viability after 24 h of incubation with 100 μg/mL of bare TiONts; however, concentra-
tions up to 20 μg/mL were not found to be cytotoxic to these ovarian cells [10]. Additionally, 
PEGylation of TiONts did not modulate TiONts effect on cell viability up to 5 μg/mL [10]. 
However, the subsequent surface functionalization of these nanotubes with Docetaxel reduces 
the drug availability and significantly increases Docetaxel IC50 in 22Rv1 cells, compared to 
free drug control [8]. As described in the next section, in vivo studies have shown that TiONts 
acts like an anchor in the tumor, which prevents drug from leaching out of the cancerous cells, 
and as a result, the loss in drug potency was not detrimental in this specific case [8].
Beyond their cytotoxicity data, TiONts have been shown to arrest cell cycle in the G2/M phase 
for both SH-B19 and U87-MG cell lines, as observed while investigating the origin of their 
radio sensitization effect in glioblastoma [32]. Indeed, an important intrinsic feature of these 
metal oxide nanotubes is their ability to potentiate gamma radiation effect on cells, making 
them an interesting candidate for combinatorial therapies on ongoing preclinical investiga-
tions (i.e., chemotherapy along with radiation therapy) [34].
3.2.2. Cellular uptake of nanotubes: the shape takes the lead
This chapter mainly focuses on metal oxide nanoparticles, however, beyond the surface 
chemistry of such materials, one of the key parameters to consider while studying nanopar-
ticle interaction with cells and tissues is their shape. Indeed, due to their needle-like mor-
phology, bare TiONts are internalized in cells not only by endocytosis, but also by diffusion 
across the plasma membrane, as observed by TEM analysis for cardiomyocytes [31], SNB19 
and U87-MG glioblastoma cell lines [32]. Nanotubes display a significant higher specific sur-
face compared to their spherical counterparts [2] and this potentially modifies their degree of 
interaction with plasma proteins and cells. Our group has observed that even by incubating 4 
times more spherical TiO2 than TiONts with cardiomyocyte cells to account for the difference in specific surface values, TiONts were internalized in much more cells than spherical TiO2 [31]. Cell penetration via diffusion, along with their increased specific area, potentially makes 
Unraveling the Safety Profile of Nanoscale Particles and Materials - From Biomedical to Environmental Applications22
them an excellent candidate as a new nanomedicine platform after careful assessment of their 
cytotoxicity in each targeted cell model.
3.2.3. Biodistribution and “tumor retention effect” of titanate nanotubes
Nanotubes display unique behavior regarding their interaction with and internalization within 
cells, as well as distribution to tissues, compared to spherical nanoparticles. Indeed, the shape is a 
critical parameter governing circulation time and biodistribution for the same material. For exam-
ple, the circulation time for tubular micelles in mice is 10 times longer than the one of spherical 
micelles [35]. Titanate nanotubes have been shown to transiently accumulate in the lungs before 
being quickly eliminated by the bladder more than 24 h following their IV injection in mice [36]. 
Lung accumulation has also been observed in the case of carbon nanotubes; however, they were 
still detected 3 months following injection [37]. Interestingly, single walled carbon nanotubes have 
been demonstrated to be uptaken in the bloodstream by a subset of monocytes that subsequently 
deliver them to the tumor [38]. Nanoparticles passively accumulate in tumor by enhanced per-
meability and retention effect (EPR effect), due to the poorly formed vasculature supporting the 
malignant cells, in combination with reduced clearance secondary to defective lymphatic drain-
age at site. While passive targeted delivery to tumor is estimated to deliver only a small fraction of 
the injected dose utilizing spherical nanoparticles, nanotubes are capable of reaching significantly 
greater accumulation than their spherical counterparts and also display greater surface area that 
potentially leads to greater effect [39]. Immune cells’ active delivery of tubular nanomaterials 
to the tumor [38], as well as the enhanced retention time of tubular-shaped nanomaterials into 
tumors [8] are attractive factors in using such particles for drug delivery. Indeed, our group has 
reported for the first time that prostate tumors retain more than 70% of docetaxel-functionalized 
titanate nanotubes up to 7 days following intratumoral injection, indirectly bypassing the well-
known multidrug resistance effect [8] (Figure 1-A). Exploring the tubular shape of nanobioma-
terials that can provide a solid “tumor retention effect” will be an important step forward in 
developing the next generations of drug delivery platforms in oncology.
3.3. Importance of the protein corona on biological interactions of nanomaterials
Understanding the in vitro and in vivo behavior of nanoparticles is one of the main objectives of 
current studies. It seems too simplistic today to draw conclusions about their behavior without 
taking into account the environment, especially the proteins present in the systems studied 
[40]. Nowadays, it is accepted that once nanoparticles are incubated in biological fluids such 
as blood, they will be covered by proteins [41]. Not only do these proteins interact with the 
chemical coatings of materials, but they mostly also modulate their biological fate [28, 42].
The nature of the coating, including resulting charge, surface chemistry and particle hydrody-
namic size, influences the adsorption of proteins on the surface of nanoparticles: the protein 
corona [43, 44]. For example, we demonstrated that bare silica beads covered by either a gold 
or a titanium oxide layer have different preferential binding to proteins [43]. Once incubated 
1 h at 37°C with fetal bovine serum (FBS), we showed that:
• naked silica nanoparticles have no interactions with neither plasminogen nor albumin (two 
of the most abundant proteins present in FBS),
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• TiO2-coated silica nanoparticles interact only with albumin, and
• gold-coated silica nanoparticles interact with both the proteins.
For PVA-coated SPIONs, the charge of the polymers also influences the protein corona [45] and 
is different for the three types of PVA-SPIONs (neutral, positively and negatively charged) incu-
bated in FBS for 1 h at 37°C. We also showed there were important differences between in vitro 
and in vivo protein coronas [28]. In the case of negatively charged PVA-SPIONs, for example, 
more than 60% of the adsorbed proteins from rat serum have sizes comprised between 30 and 
50 kDa in vitro when the main proteins (more than 50%) are below 30 kDa in vivo (15 min post 
injection) (Figure 1-B). Literature regarding the protein corona of TiONts is very limited at pres-
ent and our group aims to elucidate key aspects of the topic in the years to come. Interestingly, 
titanate nanotubes bind significantly less plasma proteins than spherical TiO2 (Degussa P25) [46], even though they display a greater specific surface [2]. These proteins include albumin, Ig heavy 
chain (mu), Ig light chain, fibrinogen (alpha, beta and gamma chains) and complement C3.
The coatings of the nanoparticles influence the nature of their protein corona. The medium 
used is also important for the interactions between materials and proteins [47]. Thus, taking 
into account not only the physicochemical properties but also the biological environment, it is 
essential to understand cellular uptake and biodistribution of nanoparticles in order to better 
control their toxicological risks.
4. Influence of nanoparticles on the biogenesis and activity of 
cellular organelles
Organelles (mitochondria, peroxisome, lysosome, endoplasmic reticulum, and Golgi appa-
ratus) are integral parts of the cells, essential for the its proper functioning. Their dysfunc-
tions can lead to serious consequences. For instance, mitochondrial alterations can go as far 
as to activate apoptosis [48], peroxisomal dysfunction affect the mitochondria, subsequently 
leading to oxidative stress and cell death [49, 50], alterations of the lysosome may have conse-
quences on the induction of autophagy and apoptosis [51], endoplasmic reticulum damages 
can lead to reticulum stress which can trigger different forms of cell death in extreme cases 
Figure 1. (A) Quantification of nanohybrid biodistribution via gamma counting 7 days post injection (mean of three 
mice ± SD) (adapted with permission from [8], DTX: docetaxel). (B) Abundance of plasma proteins found at the surface 
of SPIONs after incubation with rat serum in vitro versus in vivo (adapted with permission from [28]).
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[52], and Golgi apparatus dysfunctions can disturb post-translational modifications and vesic-
ular transport [53]. The incidence of the cytotoxicity of nanoparticles is often addressed in 
generalized terms such as induction of cell death, oxidative stress stimulation, inflammation 
activation and genotoxicity. The impact of nanoparticles on cell organelles is less known and 
must be taken into consideration as organelle dysfunctions affect general health in unexpected 
ways. As regards the peroxisome, whose dysfunctions can lead to severe neurodegenerative 
damage [54], there are currently no data on the effects of nanoparticles on this organelle.
It is therefore essential to understand the interaction of nanoparticles with cell organelles in 
terms of distribution and impact on their biogenesis and biological activities. This not only 
helps to prevent or optimize the toxic effects of nanoparticles depending on the intended 
purpose (cytoprotection or cell death induction), but also to use them specifically in nano-
medicine without side effects.
4.1. Effect of nanoparticles on mitochondria
The interaction of nanoparticles with the mitochondria (as well as the other organelles) must 
be approached with the consideration that they are either the consequence of targeted interac-
tions with specifically dedicated functionalized nanoparticles, or a random direct or indirect 
interaction which leads to unwanted side effects. This second aspect must be systematically 
taken into consideration, and integrated into a cytotoxic screening procedure which will per-
mit to specify the biological activity of nanoparticles at the mitochondrial level. In order to 
understand the toxicological interactions of nanoparticles on biogenesis and mitochondrial 
metabolism, it is necessary to specify whether they interact physically with the mitochondria 
and accumulate at specific locations such as external membrane, mitochondrial space, inter-
nal membrane and cristae. In this context, it has been shown that Gadolinium oxide (Gd2O3) nanoparticles, which have a range of biomedical uses, induce mitochondrial apoptosis by 
acting on Bcl-2 and Bax [55]. Similarly, silver nanoparticles impair mitochondrial activity and 
decrease cell viability [56]. Nanoparticles interact with mitochondria in different manner, 
based on their physicochemical nature. TiO2 nanoparticles, which are present in numerous manufactured products, induce loss of mitochondrial transmembrane potential (ΔΨm) and 
an overproduction of superoxide anions in murine microglial BV-2 cells [57]. After exposure 
with a high concentration of ZnO nanoparticles [58], BV2 cells undergo an increase in mito-
chondrial transmembrane potential (Figure 2). In addition, MTT assays have highlighted that 
SPIONs and TiONts can also affect mitochondrial integrity depending on their concentrations 
(especially at high doses) and surface coating [10]. Since numerous types of nanoparticles are 
able to induce mitochondrial dysfunctions, which can have dramatic consequences on human 
health after chronic or acute exposures, a systematic evaluation of the impact of nanoparticles 
on the mitochondria is required.
4.2. Effect of nanoparticles on the peroxisome
Peroxisome has emerged as a key regulator in overall cellular lipid and reactive oxygen spe-
cies metabolism. In mammals, these organelles have been recognized as important hubs in 
redox-, lipid-, inflammatory-, and innate immune-signaling networks. Peroxisomal dysfunc-
tions are associated with important brain diseases [54]. To exert its activities, the peroxisome 
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must interact both functionally and physically with other cell organelles, mainly mitochondria 
and endoplasmic reticulum [59, 60]. It seems therefore important to precise the effects of 
nanoparticles on peroxisome. Numerous techniques such as fluorescent microscopy and flow 
cytometry are available to estimate the impact of molecules/nanoparticles at the peroxisomal 
level [61]. Nevertheless, no data are available concerning the impact of nanoparticles on this 
organelle.
4.3. Effect of nanoparticles on the lysosome
Endocytosis is the major uptake mechanism of particles by cells [62]. The nanoparticles 
entrapped in endosomes are eventually degraded by specific enzymes present in phagoly-
sosomes, as the endosomes fuse with lysosomes. The function of lysosomes is to break down 
molecules and dispose unwanted materials [63]. This phenomenon can also limit the delivery 
of therapeutic nanoparticles to the intracellular target site. Nanoparticles depending on its 
physicochemical nature can alter the function of lysosome and subsequently favor the activa-
tion or the inhibition of autophagy [64–66]. For instance, we have observed that ZnO nanopar-
ticles induce a loss of lysosome membrane integrity in BV2 cells at high-dose exposure 
(80 mg/mL) as seen by flow cytometry detection of acridine orange (Figure 2). Additionally, 
double-membrane vesicles closely resembling autophagosomes have been observed by TEM, 
following 6 h of cardiomyocyte incubation with TiONts [31]. As the lysosomal pathway may 
have beneficial or detrimental effects on cell activity, a panel of assays is required to define the 
influence of nanoparticles on this organelle and its potential consequences in major diseases 
(metabolic diseases, cancer and neurodegenerative diseases).
Figure 2. Interaction of ZnO nanoparticles with murine microglial (BV2) cells. Nanoparticles characterized for size, 
shape, surface charge, crystal structure, chemical composition and purity were exposed to BV2 cells for a maximum 
duration of 24 h. The ZnO nanoparticles exposure induced dose-dependent increase in transmitochondrial membrane 
potential and loss of lysosomal membrane integrity as revealed by flow cytometry analysis using fluorescent probes 
DiOC6(3) and propidium iodide respectively.
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4.4. Effect of nanoparticles on the endoplasmic reticulum and Golgi apparatus
Currently limited data are available on the impact of nanoparticles on endoplasmic reticulum 
and Golgi apparatus. It has been reported that silica nanoparticles accumulate in the endoplas-
mic reticulum and triggers autophagy [67]. On the other hand, the intracellular accumulation 
of gold nanoparticles leads to inhibition of macropinocytosis and reduction of endoplasmic 
reticulum stress [68]. Thus, it appears that nanoparticles can have different effects on the endo-
plasmic reticulum. Consequently, their effects on this organelle must not be neglected.
There is evidence that some nanoparticles can be taken up by the Golgi apparatus for further 
processing; however, no additional information are available on the influence of nanopar-
ticles on the activity of the Golgi apparatus [69, 70].
Among the most appropriated techniques available in nanotoxicology, observation of cells 
and tissues by TEM is well suited. This method permits quantitative and qualitative evalua-
tion of modifications at the organelle level which are not easily detected with antigenic and 
functional changes. Various methods of flow cytometry with appropriate probes are also of 
interest to define the impact of nanoparticles on the biogenesis and activities of the organelles. 
These methods can be complemented with other methods of biochemistry, such as Western 
blot, PCR and RT-qPCR to study the nanobiointeraction at the molecular level. These meth-
ods make it possible to identify specific molecular targets and study the effects of nanopar-
ticles on signaling pathways. The development of chip-based single-cell analysis is also of 
great interest for nanotoxicity assessment [71].
Overall, the beneficial or detrimental effects of nanoparticles on the organelles are difficult to 
predict. Systemic evaluation of nanoparticle interaction with organelles using simple tech-
niques will help to minimize, if not to subdue, the biological risk associated with nanopar-
ticles on human health, as well as with the environment.
5. Zebrafish as a model for testing the toxicity of SPIONs and 
TiONts
Due to the increase of nanotechnologies in an expanding range of applications in industrial 
and biomedical purposes, those new materials require ecotoxicological, biosafety and bio-
compatibility evaluation. While nanotoxicity can be rapidly assessed in vitro, results obtained 
do not reflect complex processes that happen in full organisms and ecosystems.
Various factors must indeed be taken into account, such as the route of administration (i.e., 
route of exposure), biodistribution, long-term exposure, induction of developmental defects 
or activation of the immune system [72, 73]. However, in vivo approaches using classical 
mammalian models have strict ethical considerations, are time consuming and are expensive. 
Most importantly, throughput approaches cannot be considered via those models.
Given its many advantages, zebrafish is now a recognized model for toxicological and bio-
medical assays [74–77]. The main advantages of this species are rapid development, exter-
nal fertilization, easy observation of all developmental stages, small size, transparency of the 
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embryos and larvae, large number of embryos, ease of maintenance and close contact with 
surrounding medium (water) allowing easy interface with materials. In addition, it is possible 
to take advantage of the sequenced and annotated genome via experimental and genetic tools 
such as fluorescent microscopy, time lapse, histology, transgenic organisms, microinjection 
and ectopic expression of specific genes. For all these reasons, small fish species represent one 
of the best choices to study pharmacological/toxicological effects and physiological altera-
tions in vertebrates as a first screening step. Similarly, due to their small size, they are highly 
suitable for investigating alterations in vertebrate physiology under confined conditions [78]. 
Indeed, several zebrafish larvae can be placed into one well of 96 wells plates or one larva in 
a 384 wells plates. Finally, standardized fish embryo toxicity methods are recognized and can 
be applied to analyze nanomaterials’ effects on vertebrates [79].
Recently, zebrafish models were used to evaluate the toxicity of various nanoparticles, includ-
ing SPIONs and spherical TiO2 [80–83]. Studies in zebrafish embryos point to toxicity using concentrations of iron oxide particles >10 mg/L resulting in increased mortality, hatching 
delay and malformations [81], showing the possibility of toxicity of SPIONs at elevated 
Figure 3. Toxicity evaluation of TiONts and chitosan modified TiONts, SPIONs and TiONt-SPIONs in zebrafish 
embryos. Unless noted, SPIONs, TiONts and SPION-TiONts concentration was 50 µg/mL; negative control: water; 
positive control: 4 µg/mL of 3,4-dichloroaniline.
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concentrations. Another study revealed that SPIONs coated with cross-linked aminated dex-
tran may cause acute brain toxicity in adult zebrafish [83]. Iron overload, changes of gene 
expression and inhibition of acetylcholinesterase were proposed as causes for the observed 
neurotoxicity. In another study, SPIONs, which were non-toxic in vitro, were lethal in zebraf-
ish embryos when used at concentrations higher than 10 mg/mL [80]. Regarding TiO2 nano-tubes, they are reported to have an excellent biocompatibility [84]. However, another work 
using zebrafish as model organism showed that TiO2 nanotubes at 1 mg/L may cause unde-sired tissue accumulation in injured animals and asymmetric and shorter regeneration after 
fin amputation [82]. We analyzed SPIONs as well as unmodified and modified TiONts in 
zebrafish embryos for toxicity (Figure 3). Embryos were incubated up to 96 h post fertilization 
with different amounts of these materials (500 μg/mL for TiONts, 50 μg/mL for SPIONs and 
TiONts-SPIONs). No lethality, developmental effects (no malformation) or delayed hatching 
were observed. Even if we used higher concentrations than Park et al. [82], we did not observe 
any toxicity. In contrast to Parker, we did not treat injured animals, and we used a higher 
number of animals in the experiments.
All together, we concluded that the nanomaterials we produced do not show any obvious 
toxicity, even at high concentrations. However, to get more precise information, the zebrafish 
embryos will be analyzed by qRT-PCR for detection of stress or inflammation related gene 
expression and with fluorescent markers for apoptosis events.
6. Conclusion
The outcomes presented in this chapter are the result of collaborations between chemists, 
physico-chemists, biologists and clinicians on the field of biomedical applications of nanoparti-
cles. Such interdisciplinary collaborations are required to investigate nanotoxicity. Controlled 
nanoparticles, fully characterized and leading to stable suspensions in biological media, have 
to be prepared. Then, rapid, accurate and efficient testing strategies have to be developed to 
assess the effect of these emerging materials on the human health and the environment: in 
vitro assays but also in vivo evaluation (biodistribution, retention, elimination and ecotoxicity). 
All the skills (chemistry, physico-chemistry, nanomaterials engineering, toxicology, biology 
and medicine) are required to achieve this goal.
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